ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Efficacy Study of LJP 394 (Abetimus Sodium) to Treat Lupus Kidney Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00035308
Recruitment Status : Completed
First Posted : May 3, 2002
Last Update Posted : September 25, 2006
Sponsor:
Information provided by:
La Jolla Pharmaceutical Company

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Study Completion Date : December 2002